Christopher Jeffers

Chris Jeffers, the senior vice president of life sciences at BR BioAdvisory Services, brings over 25 years of experience in the life sciences sector, encompassing a wide range of legal and non-legal executive roles.

During his career, Chris spent more than 20 years as a practicing attorney, holding positions as a former partner at both Mintz Levin and Womble Carlyle. In this capacity, he represented diverse companies, from individual inventors to major pharmaceutical firms, providing valuable assistance in addressing challenges encountered throughout the lifecycle of life science companies. His legal practice primarily centered on handling complex transactions within the biotechnology, pharmaceutical and agricultural biotechnology sectors. Additionally, he served as an advisor to the management teams and boards of numerous small and mid-sized biotechnology companies. Chris served as the outside general counsel to Viela Bio (now Amgen), NexImmune, RegenMed (now ProKidney) and numerous other life science companies.

In addition to his former law practice, Chris is the founder and former CEO of Seguro Surgical, Regio Biosciences and Primera Therapeutics. Chris also founded and acted as the managing partner of Hibiscus BioTechnology, The BioForge Group and FirstStage Bioventures, companies dedicated to identifying and developing early-stage technologies. Prior to these roles, Chris served as the general counsel of Alba Therapeutics. Currently, he serves on the board of Regio Biosciences and is chairman of the board at Primera Therapeutics. Previously, Chris was previously on the board of Cellevolve, BioRosa and Mayflower Biotechnology.

Chris earned a Ph.D. in biochemistry from the University of Houston, where he was an NIH pre-doctoral biophysics fellow at Rice University. He later became an NIH postdoctoral fellow at Johns Hopkins University School of Medicine, focusing on the protein structure and function of the cystic fibrosis transmembrane conductance regulator (CFTR). He obtained his law degree from Georgetown University and currently holds adjunct faculty appointments in both the Johns Hopkins Whiting School of Engineering and Johns Hopkins Carey Business School.